Search results for "Lope"

showing 10 items of 2014 documents

Effect of lactose, lactulose and bisacodyl on gastrointestinal transit studied by metal detector.

2007

SUMMARY Aim and methods: To study the effect of 45 g lactose, 30 g lactulose and 10 mg bisacodyl on gastrointestinal transit in 30 healthy volunteers by metal detector and Hinton marker method. The first set of measurements were performed under standard conditions. In a second stage, transit was slowed to twice the original value by loperamide to simulate constipation conditions. Results: Bisacodyl drastically accelerated small and large intestinal transit. Colonic transit was shortened to 23 % and to 31% of control values, without and with loperamide. Bisacodyl increased stool weight and decreased stool consistency in all persons. Lactulose marginally shortened small intestinal transit (P=…

AdultBisacodylMalemedicine.medical_specialtyLoperamideConstipationColonmedicine.medical_treatmentLaxativeLactoseGastroenterologyLoperamideLactulosechemistry.chemical_compoundInternal medicineIntestine SmallmedicineHumansPharmacology (medical)Intestine LargeBisacodylLactoseDefecationGastrointestinal TransitHepatologyGastrointestinal transitdigestive oral and skin physiologyGastroenterologyLarge intestinalLactuloseMicrosphereschemistryGastric EmptyingFemalemedicine.symptommedicine.drugAlimentary pharmacologytherapeutics
researchProduct

Differences in platelet growth factor release and leucocyte kinetics during autologous platelet gel formation.

2006

Three commercial systems for whole blood separation were compared to obtain the buffy coat composed of platelet-rich plasma (BC-PRP) and leucocytes . These samples of the buffy coat were used to make a platelet gel (PG), which was used to measure platelet growth factor (PGF) release, to perform a white blood cell (WBC) count and to measure myeloperoxidase (MPO) release from WBCs. Aliquots of whole blood obtained from ten volunteers were distributed either to a blood cell separator (The Electa Cell-Separator (TM), E-CS) or to a tabletop centrifuge (Gravitational Platelet Sequestration System (TM), GPS) to prepare the BC-PRP. The third system combines the BC-PRP production by E-CS with a micr…

AdultBlood PlateletsBuffy coatFibrin Tissue AdhesiveBlood cellTransforming Growth Factor beta1Blood Transfusion AutologousLeukocyte CountThrombinTransforming Growth Factor betaWhite blood cellmedicineLeukocytesHumansPlateletPlatelet activationWhole bloodPeroxidasePlatelet-Derived Growth FactorWound HealingChromatographybiologyChemistryHematologyPlatelet Activationmedicine.anatomical_structureBiochemistryMyeloperoxidasebiology.proteinBlood Component RemovalGelsmedicine.drugTransfusion medicine (Oxford, England)
researchProduct

Stable changes in CD4+ T lymphocyte miRNA expression after exposure to HIV-1

2012

Abstract MicroRNAs (miRNAs) inhibit HIV-1 expression by either modulating host innate immunity or by directly interfering with viral mRNAs. We evaluated the expression of 377 miRNAs in CD4+ T cells from HIV-1 élite long-term nonprogressors (éLTNPs), naive patients, and multiply exposed uninfected (MEU) patients, and we observed that the éLTNP patients clustered with naive patients, whereas all MEU subjects grouped together. The discriminatory power of miRNAs showed that 21 miRNAs significantly differentiated éLTNP from MEU patients and 23 miRNAs distinguished naive from MEU patients, whereas only 1 miRNA (miR-155) discriminated éLTNP from naive patients. We proposed that miRNA expression ma…

AdultCD4-Positive T-LymphocytesMaleTime FactorsImmunologyHIV InfectionsHIV Envelope Protein gp120BiologyBiochemistryImmune systemmultiply exposed uninfectedmicroRNAHumansDroshamiRNAInnate immune systemélite long-term nonprogressorsGene Expression ProfilingCell BiologyHematologyT lymphocyteMiddle AgedViral LoadMicroarray AnalysisHIV-1; miRNA; CD4+ T cells; élite long-term nonprogressors; multiply exposed uninfected.CD4+ T cellsIn vitroMicroRNAsGene Expression RegulationCase-Control StudiesImmunologyHIV-1biology.proteinFemaleEx vivoDicerBlood
researchProduct

PAI-1 Levels are Related to Insulin Resistance and Carotid Atherosclerosis in Subjects with Familial Combined Hyperlipidemia

2017

Familial combined hyperlipidemia (FCH) is a primary atherogenic dyslipidemia with insulin resistance and increased cardiovascular risk. Plasminogen activator inhibitor type 1 (PAI-1) and myeloperoxidase (MPO) activity are associated with proinflammatory and atherothrombotic risk. Our aim was to study the role played by PAI-1 and MPO activity in the carotid atherosclerosis prevalence in FCH subjects. 36 FCH unrelated subjects (17 women) were matched by age and body weight with 36 healthy normolipidemic subjects (19 female). Blood lipids, glucose, insulin, insulin resistance (homeostasis model assessment (HOMA)), MPO, and PAI-1 were determined in both groups. Carotid intima media thickness (…

AdultCarotid Artery DiseasesMale0301 basic medicinemedicine.medical_specialtyWaistmedicine.medical_treatmentHyperlipidemia Familial CombinedBlood lipids030204 cardiovascular system & hematologyGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicineInsulin resistanceInternal medicinePlasminogen Activator Inhibitor 1medicineHumansPeroxidasebiologybusiness.industryInsulinGeneral MedicineMiddle Agedmedicine.disease030104 developmental biologyEndocrinologyIntima-media thicknessCase-Control StudiesMyeloperoxidasebiology.proteinFemaleInsulin ResistanceMetabolic syndromebusinessBody mass indexJournal of Investigative Medicine
researchProduct

Effect of loperamide on jejunal electrolyte and water transport, prostaglandin E 2-induced secretion and intestinal transit time in man

1991

Jejunal perfusion was performed in 12 healthy volunteers to evaluate the dose dependent effects of loperamide on intestinal absorption, stimulated secretion and transit. In 6 volunteers intestinal perfusion of the jejunal segment with isotonic NaCl solution was followed by addition of loperamide in increasing doses (2–8 mg·l−1). The volunteers were pretreated with 1 mg·l−1 prostaglandin E2 (PgE2) in the perfusate before addition of 4 mg·l−1 loperamide. Phenolsulphonphtalein (PSP) boluses (2 ml) were given to measure mean transit time (MTT). Loperamide 2 mg·l−1 converted the minor secretion after perfusion with the standard solution (water −1.45 ml·min−1, Na −0.09 and Cl −0.04 mmol·min−1) to…

AdultDiarrheaMalemedicine.medical_specialtyLoperamideAdolescentAbsorption (skin)LoperamideDinoprostoneIntestinal absorptionJejunumChloridesInternal medicinemedicineHumansPharmacology (medical)Prostaglandin E2Gastrointestinal TransitPharmacologyWater transportDose-Response Relationship DrugChemistrySodiumBiological TransportGeneral MedicineWater-Electrolyte BalanceJejunumEndocrinologymedicine.anatomical_structureIntestinal AbsorptionMechanism of actionmedicine.symptomPerfusionmedicine.drugEuropean Journal of Clinical Pharmacology
researchProduct

Influence of Senna, Fibre, and Fibre + Senna on Colonic Transit in Loperamide-induced Constipation

1993

Retarded colonic transit and disturbed defecation are the most prominent pathophysiological mechanisms in constipation. Both may be influenced by bulking agents and by laxatives such as senna. Direct measurements of the influence of such substances on colonic transit are rare mainly because of technical problems. We measured gastric emptying, small and large intestinal transit in 24 healthy volunteers by a newly developed method employing a metal detector. Twelve persons taking a normal diet received loperamide in a dose sufficient to double the individual transit time. All subjects measured gastrointestinal transit time under normal conditions and with Sennatin containing purified sennosid…

AdultDietary FiberMalemedicine.medical_specialtyLoperamideConstipationAdolescentSennaCassiaLoperamideGastroenterologyFecesCassiaInternal medicinemedicineHumansGastrointestinal TransitFecesPharmacologyPlants Medicinalbiologybusiness.industrySenna Extractdigestive oral and skin physiologyGeneral Medicinebiology.organism_classificationIntestinesDrug CombinationsGastric EmptyingDefecationFemaleDietary fibermedicine.symptombusinessConstipationmedicine.drugPharmacology
researchProduct

POSTPONING OR REJECTING PARENTHOOD? RESULTS OF A SURVEY AMONG FEMALE ACADEMIC PROFESSIONALS

2003

The current surge in childlessness is often seen as an alternative lifestyle amidst growing pluralism and individualism. The results of this study indicate that several subgroups of childless women need to be differentiated: those who actively decide to forgo children in favour of other life pursuits and those who merely defer the decision. Both have accumulated a high degree of human capital in their education or career-building paths. Thus, the increase of a woman's time invested in education or career formation takes its toll on the time available for childrearing. A survey performed among female academics (N=193) brought to light that among childless women, many merely mean to postpone …

AdultEconomic growthUniversitiesmedia_common.quotation_subjectOccupational prestigePopulationFertilityHuman capitalGermanySurveys and QuestionnairesHumansSociologyeducationSocioeconomic statusmedia_commoneducation.field_of_studyMarital StatusParentingPublic Health Environmental and Occupational HealthGeneral Social SciencesMiddle AgedFacultyPluralism (political theory)Family Planning ServicesChildlessnessEducational StatusFemaleDemographic economicsDeveloped countryJournal of Biosocial Science
researchProduct

The choice between retirement and bridge employment: a continuity theory and life course perspective.

2009

The rapid aging of the workforce in most developed countries, and the strengthening presence of bridge employment among older employees, has brought about a need for a deeper theoretical and practical understanding of this employment phenomenon. This study examined the concept of bridge employment from a continuity theory and life course perspective. Several personal and job-related antecedents of 539 middle-aged and older U.S. Federal Government employees' intentions of full retirement or engagement in bridge employment were investigated. A multinomial logistic regression analysis provided support for most of the hypotheses on the antecedents of full retirement and overall bridge employme…

AdultEmploymentMaleAgingAdolescentTheory of MindBridge (interpersonal)Continuity theoryYoung AdultPhenomenonDevelopmental and Educational PsychologyHumansSociologyPractical implicationsAgedRetrospective StudiesGovernmentRetirementMiddle AgedUnited StatesWorkforceLife course approachDemographic economicsFemaleGeriatrics and GerontologyDeveloped countrySocial psychologyInternational journal of aginghuman development
researchProduct

Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism.

2005

CONTEXT: We undertook this study to estimate the prevalence of the various androgen excess disorders using the new criteria suggested for the diagnosis of polycystic ovary syndrome (PCOS). SETTING: The study was performed at two endocrine departments at the University of Palermo (Palermo, Italy). PATIENTS: The records of all patients referred between 1980 and 2004 for evaluation of clinical hyperandrogenism were reevaluated. All past diagnoses were reviewed using the actual diagnostic criteria. To be included in this study, the records of the patients had to present the following available data: clinical evaluation of hyperandrogenism, body weight and height, testosterone (T), free T, dehyd…

AdultHirsutismAdolescent17-alpha-HydroxyprogesteroneBody WeightOvaryAlopeciaBody HeightBody Mass IndexPelvisDiagnosis DifferentialPolycystic ovary syndrome HyperandrogenismNeoplasmsAcne VulgarisAndrogensHumansFemaleTestosteroneHyperandrogenismProgesteroneAnovulationPolycystic Ovary SyndromeRetrospective StudiesUltrasonography
researchProduct

Gastrointestinal disturbances and their management in miglustat‐treated patients

2011

Miglustat (Zavesca®) is approved for the oral treatment of adult patients with mild to moderate type 1 Gaucher disease (GD1) for whom enzyme replacement therapy is unsuitable, and for the treatment of progressive neurological manifestations in adult and paediatric patients with Niemann-Pick disease type C (NP-C). Gastrointestinal disturbances such as diarrhoea, flatulence and abdominal pain/discomfort have consistently been reported as the most frequent adverse events associated with miglustat during clinical trials and in real-world clinical practice settings. These adverse events are generally mild or moderate in severity, occurring mostly during the initial weeks of therapy. The mechanis…

AdultLoperamideAbdominal painmedicine.medical_specialty1-DeoxynojirimycinMalabsorptionDrug-Related Side Effects and Adverse ReactionsGastrointestinal DiseasesModels BiologicalGastroenterologyInternal medicineMiglustatGeneticsmedicineHumansEnzyme InhibitorsChildAdverse effectGenetics (clinical)Clinical Trials as TopicGaucher Diseasebusiness.industryEnzyme replacement therapymedicine.diseaseClinical trialEndocrinologymedicine.symptombusinessFlatulencemedicine.drugJournal of Inherited Metabolic Disease
researchProduct